智通财经APP获悉，康龙化成(03759)涨超3%，截至发稿，涨2.6%，报19.76港元，成交额1900.2万港元。
花旗发布研报称，对康龙化成展开为期90天的正面催化观察，主要催化剂为公司即将公布2025年全年业绩、订单增长加速公司今年的指引更乐观。报告指出，公司将成为客户需求复苏的领先指标，并为未来收入增长提供更清晰指引，可能导致今财年指引高于市场共识，并推动股价正面重估。花旗对公司今年每股盈利的预测较市场共识高出4%。
该行认为，公司是药物研发业务的全球领导者，正随着中国CRO行业的增长趋势发展；集团在维持药物研发领导地位同时，亦正扩展至下游的后期临床开发和商业化生产，并涉足生物制剂领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.